Send me a link:

*Text messaging rates may apply.

 Dow Down 0.16% Nasdaq Up 0.40%

Inovio Pharmaceuticals, Inc. (INO)

-NYSE MKT
13.10 Jul 23, 4:02PM EDT
|Pre-Market : 12.89 Down 0.21 (1.60%) 9:15AM EDT - Nasdaq Real Time Price
Prev Close:13.10
Open:N/A
Bid:12.89 x 300
Ask:12.90 x 5000
1y Target Est:19.20
Beta:3.38
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:4.88 - 15.80
Volume:2,705
Avg Vol (3m):1,710,520
Market Cap:788.06M
P/E (ttm):N/A
EPS (ttm):-1.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for INO

Comparison

Symbol% ChgMkt Cap
INO 0.00%788.06M
AZN94.50B
PFE193.85B
SNY137.23B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):54.84
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.66
Quarterly EPS Est (Jun-14) :-0.19
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Inovio Pharmaceuticals, Inc., together with its subsidiaries, discovers, develops, and develops synthetic vaccines and immune therapies focusing on cancers and infectious diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback